Jeffrey N. Baldwin, PharmD, FAPhA, FASHP

Jeffrey N. Baldwin, PharMD, FAPhA, FASHPEmeritus Professor

Department of Pharmacy Practice and Science
College of Pharmacy
University of Nebraska Medical Center
986145 Nebraska Medical Center
Omaha, NE 68198-6145
402-559-6498 (Office)
402-559-5673 (Fax)
Email
Curriculum Vitae available upon request

Teaching Activities:
Dr. Baldwin was the primary instructor and course coordinator for Substance Abuse (PHPR 621) and Recovering from Addictions (PHPR 623) courses until 2021.

Research Activities/Interests: 
Dr. Baldwin’s research was primarily in the area of characterization of substance use disorder (SUD) attitudes and behaviors in health professionals. Additional scholarly activities have included promotion of active learning in pharmacy education, development of standards for SUD assistance for pharmacy colleges and professionals, development of guidelines for pediatric and substance use disorder education in pharmacy, and promotion of professional and public education about SUDs.

Recent Publications:

  1. Baldwin JN. A guided abstinence experience to illustrate addiction recovery principles. Am J Pharm Educ, 2008; 72(4) Article 78.
  2. Baldwin JN, Bartek JK, Scott DM, Davis-Hall RE, DeSimone EM. Survey of alcohol and other drug use attitudes and behaviors in nursing students. Subst Abuse. 2009; 30:230-38.
  3. Baldwin JN, Scott DM, DeSimone EM, Forrester JH, Fankhauser MS. Substance use attitudes and behaviors at three pharmacy colleges. Subst Abuse. 2011; 32:27-35.
  4. Beck DE, Baldwin JN, Raehl CL, Speedie MK, Yanchick VA, Kerr RA. Roles of the pharmacy academy in informing consumers about the new American pharmacist. Am J Pharm Educ, 2011; 75(10) Article S5.
  5. Cross WJ, Baldwin JN, Nash KA. Chapter 9. Substance use disorders in the pharmacy professional. In Norton M, ed. The Pharmacists’ Guide to Opioid Use Disorders, Bethesda MD: American Society of Health-System Pharmacists; 2018.
  6. Baldwin JN. Nash KA. Chapter 10. Future educational curriculum requirements for pharmacy practice. In Norton M, ed. The Pharmacists’ Guide to Opioid Use Disorders, Bethesda MD: American Society of Health-System Pharmacists; 2018.
  7. Speedie MK, Baldwin JN, Carter RA, Raehl CL, Yanchick VA, Maine LL. Cultivating ‘habits of mind’ in the scholarly pharmacy clinician. Am J Pharm Educ, 2012; 76(6) Article S3.
  8. Raehl CL, Baldwin JN, Carter RA, Crabtree BL, Yanchick VA, Maine LL. Game changers in education and health care. Am J Pharm Educ, 2013; 77(10) Article S18.
  9. Yanchick VA, Baldwin JN, Bootman JL, Carter RA, Crabtree BL, Maine LL. Diversity and Inclusion in Pharmacy Education. Am J Pharm Educ, 2014; 78(10) Article S21.
  10. Baldwin JN, Bootman JL, Carter RA, Crabtree BL, Piascik P, Ekoma JO, Maine LL. Pharmacy practice, education and research in the era of big data. Am J Pharm Educ, 2015; 78(10) Article S26. Available online at http://www.aacp.org/governance/HOD/Documents/Argus%202015%20report.pdf.